MARKET

RVTY

RVTY

Revvity Inc
NYSE
90.92
+0.28
+0.31%
Opening 10:20 12/07 EST
OPEN
90.59
PREV CLOSE
90.64
HIGH
90.95
LOW
90.25
VOLUME
35.94K
TURNOVER
0
52 WEEK HIGH
150.17
52 WEEK LOW
79.50
MARKET CAP
11.22B
P/E (TTM)
15.48
1D
5D
1M
3M
1Y
5Y
Should Weakness in Revvity, Inc.'s (NYSE:RVTY) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Revvity's 2.8% roe is below the average for its industry. The company's net income growth of 14% over the past five years is lower than the industry average. Revvity has a low return on equity, meaning it is efficient at turning profits into profits. It is expected to have a higher roe than the average industry growth rate of 12%. Revvity's roe of 2.7% is below its annual earnings growth rate.
Simply Wall St · 3d ago
Weekly Report: what happened at RVTY last week (1127-1201)?
Weekly Report · 3d ago
Revvity Inc: Statement of changes in beneficial ownership of securities
Press release · 11/29 22:09
Weekly Report: what happened at RVTY last week (1120-1124)?
Weekly Report · 11/27 09:04
The Math Shows RWL Can Go To $92
NASDAQ · 11/22 11:38
Weekly Report: what happened at RVTY last week (1113-1117)?
Weekly Report · 11/20 09:04
Weekly Report: what happened at RVTY last week (1106-1110)?
Weekly Report · 11/13 09:04
After losing 32% in the past year, Revvity, Inc. (NYSE:RVTY) institutional owners must be relieved by the recent gain
Simply Wall St · 11/09 11:42
More
About RVTY
Revvity, Inc. is a provider of products, services and solutions for the diagnostics and life sciences. The Company is focused on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics, and more. Its Life Sciences segment provides products and services targeted towards the life sciences market. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. Its portfolio includes research and development (R&D), clinical and diagnostics, platforms and automation, signals software, and advanced services and licensing. It offers genomic analysis, protein analysis, cell analysis, and research solutions. It offers clinical and diagnostics in the field of reproductive health, infectious diseases, autoimmunity, endocrinology, allergy, cancer, neurodegeneration, and rapid patient testing.

Webull offers Revvity Inc stock information, including NYSE: RVTY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVTY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVTY stock methods without spending real money on the virtual paper trading platform.